RAPT Therapeutics Gestion
Gestion contrôle des critères 2/4
RAPT Therapeutics' CEO is Brian Wong, appointed in Aug 2015, has a tenure of 9.25 years. total yearly compensation is $6.59M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 1.41% of the company’s shares, worth $1.10M. The average tenure of the management team and the board of directors is 4.8 years and 7.5 years respectively.
Informations clés
Brian Wong
Directeur général
US$6.6m
Rémunération totale
| Pourcentage du salaire du PDG | 9.2% |
| Durée du mandat du directeur général | 9.3yrs |
| Propriété du PDG | 1.4% |
| Durée moyenne d'occupation des postes de direction | 4.8yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 7.5yrs |
Mises à jour récentes de la gestion
Recent updates
RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus
Jul 24Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky
Jun 13
RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity
May 20Is RAPT Therapeutics (NASDAQ:RAPT) In A Good Position To Invest In Growth?
Feb 21We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
Sep 12We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
May 10We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Feb 07We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Oct 12RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jan 25RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Oct 15RAPT Therapeutics (RAPT) skyrockets 100% on positive RPT193 data in early-stage atopic dermatitis study
Jun 14RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jun 08Should You Take Comfort From Insider Transactions At RAPT Therapeutics, Inc. (NASDAQ:RAPT)?
Mar 15We Think RAPT Therapeutics (NASDAQ:RAPT) Can Easily Afford To Drive Business Growth
Feb 15
RAPT Therapeutics' (NASDAQ:RAPT) Stock Price Has Reduced 56% In The Past Year
Jan 18RAPT Therapeutics: Interesting Asset, But Doubtful History And Bad Market Reaction
Jan 08Here's What RAPT Therapeutics, Inc.'s (NASDAQ:RAPT) Shareholder Ownership Structure Looks Like
Dec 21The Independent Chairman of the Board of RAPT Therapeutics, Inc. (NASDAQ:RAPT), William Rieflin, Just Bought 12% More Shares
Nov 23Earnings Beat: RAPT Therapeutics, Inc. (NASDAQ:RAPT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Nov 19RAPT Therapeutics tumbles 25% despite promising FLX475 data in multiple cancers
Nov 16Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$120m |
| Mar 31 2024 | n/a | n/a | -US$118m |
| Dec 31 2023 | US$7m | US$605k | -US$117m |
| Sep 30 2023 | n/a | n/a | -US$109m |
| Jun 30 2023 | n/a | n/a | -US$99m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$5m | US$580k | -US$84m |
| Sep 30 2022 | n/a | n/a | -US$79m |
| Jun 30 2022 | n/a | n/a | -US$76m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$540k | -US$69m |
| Sep 30 2021 | n/a | n/a | -US$64m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$4m | US$500k | -US$53m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$49m |
| Mar 31 2020 | n/a | n/a | -US$47m |
| Dec 31 2019 | US$2m | US$447k | -US$43m |
| Sep 30 2019 | n/a | n/a | -US$39m |
| Jun 30 2019 | n/a | n/a | -US$40m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$1m | US$425k | -US$36m |
Rémunération vs marché: Brian's total compensation ($USD6.59M) is above average for companies of similar size in the US market ($USD655.65K).
Rémunération et revenus: Brian's compensation has increased whilst the company is unprofitable.
PDG
Brian Wong (52 yo)
9.3yrs
Titularisation
US$6,591,617
Compensation
Dr. Brian Russell Wong, M.D., Ph.D. serves as Venture Partner at The Column Group, LLC since joining the firm in 2022. He has been Chief Executive Officer and Director at RAPT Therapeutics, Inc. since Augu...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, President & Director | 9.3yrs | US$6.59m | 1.41% $ 1.1m | |
| CFO, Principal Accounting Officer & Secretary | 4.9yrs | US$2.18m | 0.034% $ 26.2k | |
| Chief Medical Officer | 9.5yrs | US$1.90m | 0.045% $ 35.1k | |
| Vice President of Technology | no data | pas de données | pas de données | |
| Chief Scientific Officer | 5.4yrs | US$1.48m | 0.074% $ 57.6k | |
| General Counsel | 1.8yrs | pas de données | pas de données | |
| Chief Human Resources Officer | 2.5yrs | pas de données | pas de données | |
| Senior Vice President of Quantitative & Computational Biology | 4.7yrs | pas de données | pas de données | |
| Senior Vice President of Drug Discovery & Preclinical Development | 5.8yrs | pas de données | pas de données | |
| Senior Vice President of Regulatory Affairs & Quality Assurance | 2.2yrs | pas de données | pas de données | |
| Senior Vice President of Technical Operations | less than a year | pas de données | pas de données |
4.8yrs
Durée moyenne de l'emploi
57.5yo
Âge moyen
Gestion expérimentée: RAPT's management team is considered experienced (4.8 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO, President & Director | 9.3yrs | US$6.59m | 1.41% $ 1.1m | |
| Independent Chairman of the Board | 9.5yrs | US$300.28k | 0.27% $ 211.2k | |
| Independent Director | 4.9yrs | US$277.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | 7.5yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | 7.5yrs | pas de données | pas de données | |
| Chairman of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données | |
| Member of Scientific Advisory Board | 7.2yrs | pas de données | pas de données | |
| Member of Scientific Advisory Board | 5.3yrs | pas de données | pas de données | |
| Independent Director | 6.8yrs | US$267.78k | 0% $ 0 | |
| Independent Director | 7.9yrs | US$260.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | pas de données | pas de données |
7.5yrs
Durée moyenne de l'emploi
65yo
Âge moyen
Conseil d'administration expérimenté: RAPT's board of directors are considered experienced (7.5 years average tenure).